Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype

被引:123
|
作者
Galbiati, F
Volonté, D
Chu, JB
Li, M
Fine, SW
Fu, MF
Bermudez, J
Pedemonte, M
Weidenheim, KM
Pestell, RG
Minetti, C
Lisanti, MP
机构
[1] Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA
[2] Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA
[3] Yeshiva Univ Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA
[4] Yeshiva Univ Albert Einstein Coll Med, Dept Neuropathol & Pathol, Bronx, NY 10461 USA
[5] Yeshiva Univ Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA
[6] Univ Genoa, Ist Gastlili, Serv Malattie Neuromuscolari, I-16147 Genoa, Italy
关键词
D O I
10.1073/pnas.160249097
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
It recently was reported that Duchenne muscular dystrophy (DMD) patients and mdx mice have elevated levels of caveolin-3 expression in their skeletal muscle. However, it remains unknown whether increased caveolin-3 levels in DMD patients contribute to the pathogenesis of DMD. Here, using a genetic approach, we test this hypothesis directly by overexpressing wild-type caveolin-3 as a transgene in mice, Analysis of skeletal muscle tissue from caveolin-3- overexpressing transgenic mice reveals: (i) a dramatic increase in the number of sarcolemmal muscle cell caveolae; (ii) a preponderance of hypertrophic, necrotic, and immature/regenerating skeletal muscle fibers with characteristic central nuclei; and (iii) down-regulation of dystrophin and beta-dystroglycan protein expression. In addition, these mice show elevated serum creatine kinase revels, consistent with the myo-necrosis observed morphologically. The Duchenne-like phenotype of caveolin-3 transgenic mice will provide an important mouse model for understanding the pathogenesis of DMD in humans.
引用
收藏
页码:9689 / 9694
页数:6
相关论文
共 42 条
  • [21] Multiple regulatory events controlling the expression and localization of utrophin in skeletal muscle fibers:: insights into a therapeutic strategy for Duchenne muscular dystrophy
    Jasmin, BJ
    Angus, LM
    Bélanger, G
    Chakkalakal, JV
    Gramolini, AO
    Lunde, JA
    Stocksley, MA
    Thompson, J
    JOURNAL OF PHYSIOLOGY-PARIS, 2002, 96 (1-2) : 31 - 42
  • [22] Mechanical stress activates the nuclear factor-kappaB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy
    Kumar, A
    Boriek, AM
    FASEB JOURNAL, 2003, 17 (03): : 386 - 396
  • [23] Molecular pathways involved in the control of contractile and metabolic properties of skeletal muscle fibers as potential therapeutic targets for Duchenne muscular dystrophy
    Bonato, Agnese
    Raparelli, Giada
    Caruso, Maurizia
    FRONTIERS IN PHYSIOLOGY, 2024, 15
  • [24] Plasma membrane removal in rat skeletal muscle fibers reveals caveolin-3 hot-spots at the necks of transverse tubules
    Murphy, Robyn M.
    Mollica, Janelle P.
    Lamb, Graham D.
    EXPERIMENTAL CELL RESEARCH, 2009, 315 (06) : 1015 - 1028
  • [25] Cyclin D3 deficiency promotes a slower, more oxidative skeletal muscle phenotype and ameliorates pathophysiology in the mdx mouse model of Duchenne muscular dystrophy
    Bonato, Agnese
    Raparelli, Giada
    Luvisetto, Siro
    Forconi, Flavia
    Cosentino, Marianna
    Tirone, Felice
    Rizzuto, Emanuele
    Caruso, Maurizia
    FASEB JOURNAL, 2023, 37 (07):
  • [26] DOCK3 is a dosage-sensitive regulator of skeletal muscle and Duchenne muscular dystrophy-associated pathologies
    Reid, Andrea L.
    Wang, Yimin
    Samani, Adrienne
    Hightower, Rylie M.
    Lopez, Michael A.
    Gilbert, Shawn R.
    Ianov, Lara
    Crossman, David K.
    Dell'Italia, Louis J.
    Millay, Douglas P.
    van Groen, Thomas
    Halade, Ganesh, V
    Alexander, Matthew S.
    HUMAN MOLECULAR GENETICS, 2020, 29 (17) : 2855 - 2871
  • [27] Skeletal muscle-specific Sidt2 knockout in mice induced muscular dystrophy-like phenotype
    Liu, Huan
    Jiang, Wenjun
    Chen, Xueru
    Chang, Guoying
    Zhao, Lei
    Li, Xihua
    Zhang, Huiwen
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2018, 85 : 259 - 270
  • [28] Mimicking sarcolemmal damage in vitro: a contractile 3D model of skeletal muscle for drug testing in Duchenne muscular dystrophy
    Tejedera-Villafranca, Ainoa
    Montolio, Marisol
    Ramon-Azcon, Javier
    Fernandez-Costa, Juan M.
    BIOFABRICATION, 2023, 15 (04)
  • [29] A muscle fatigue-like contractile decline was recapitulated using skeletal myotubes from Duchenne muscular dystrophy patient-derived iPSCs
    Uchimura, Tomoya
    Asano, Toshifumi
    Nakata, Takao
    Hotta, Akitsu
    Sakurai, Hidetoshi
    CELL REPORTS MEDICINE, 2021, 2 (06)
  • [30] De novo revertant fiber formation and therapy testing in a 3D culture model of Duchenne muscular dystrophy skeletal muscle
    Ebrahimi, Majid
    Lad, Heta
    Fusto, Aurora
    Tiper, Yekaterina
    Datye, Asiman
    Nguyen, Christine T.
    Jacques, Erik
    Moyle, Louise A.
    Nguyen, Thy
    Musgrave, Brennen
    Chavez-Madero, Carolina
    Bigot, Anne
    Chen, Chun
    Turner, Scott
    Stewart, Bryan A.
    Pegoraro, Elena
    Vitiello, Libero
    Gilbert, Penney M.
    ACTA BIOMATERIALIA, 2021, 132 : 227 - 244